Johansen JS - Search Results

1

Serum YKL-40 and gestational diabetes - an observational cohort study.

Gybel-Brask D, Johansen JS, Christiansen IJ, Skibsted L, Høgdall EV. Gybel-Brask D, et al. Among authors: johansen js. APMIS. 2016 Sep;124(9):770-5. doi: 10.1111/apm.12573. Epub 2016 Jul 25. APMIS. 2016. PMID: 27457220

2

High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.

Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ. Cintin C, et al. Among authors: johansen js. Cancer. 2002 Jul 15;95(2):267-74. doi: 10.1002/cncr.10644. Cancer. 2002. PMID: 12124825 Free article.

3

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer.

Dehn H, Høgdall EV, Johansen JS, Jørgensen M, Price PA, Engelholm SA, Høgdall CK. Dehn H, et al. Among authors: johansen js. Acta Obstet Gynecol Scand. 2003 Mar;82(3):287-93. doi: 10.1034/j.1600-0412.2003.00010.x. Acta Obstet Gynecol Scand. 2003. PMID: 12694127 Free article.

4

Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease.

Nøjgaard C, Johansen JS, Christensen E, Skovgaard LT, Price PA, Becker U; EMALD Group. Nøjgaard C, et al. Among authors: johansen js. J Hepatol. 2003 Aug;39(2):179-86. doi: 10.1016/s0168-8278(03)00184-3. J Hepatol. 2003. PMID: 12873813

5

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival.

Høgdall EV, Johansen JS, Kjaer SK, Price PA, Christensen L, Blaakaer J, Bock JE, Glud E, Høgdall CK. Høgdall EV, et al. Among authors: johansen js. Oncol Rep. 2003 Sep-Oct;10(5):1535-8. Oncol Rep. 2003. PMID: 12883737

6

High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer.

Jensen BV, Johansen JS, Price PA. Jensen BV, et al. Among authors: johansen js. Clin Cancer Res. 2003 Oct 1;9(12):4423-34. Clin Cancer Res. 2003. PMID: 14555515

7

Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity?

Johansen JS, Milman N, Hansen M, Garbarsch C, Price PA, Graudal N. Johansen JS, et al. Respir Med. 2005 Apr;99(4):396-402. doi: 10.1016/j.rmed.2004.09.016. Epub 2004 Nov 5. Respir Med. 2005. PMID: 15763444 Free article.

8

High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia.

Bergmann OJ, Johansen JS, Klausen TW, Mylin AK, Kristensen JS, Kjeldsen E, Johnsen HE. Bergmann OJ, et al. Among authors: johansen js. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8644-52. doi: 10.1158/1078-0432.CCR-05-1317. Clin Cancer Res. 2005. PMID: 16361549

9

Serum YKL-40, a new prognostic biomarker in cancer patients?

Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Johansen JS, et al. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):194-202. doi: 10.1158/1055-9965.EPI-05-0011. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492905 Review.

10

Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells.

Mylin AK, Rasmussen T, Johansen JS, Knudsen LM, Nørgaard PH, Lenhoff S, Dahl IM, Johnsen HE; Nordic Myeloma Study Group. Mylin AK, et al. Among authors: johansen js. Eur J Haematol. 2006 Nov;77(5):416-24. doi: 10.1111/j.0902-4441.2006.t01-1-EJH2879.x. Epub 2006 Aug 23. Eur J Haematol. 2006. PMID: 16930142 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters